Chapter 34 Parasiticide Toxicoses: Avermectins

  1. Griffin J et al: Selamectin is a potent substrate and inhibitor of human canine P-glycoprotein, J Vet Pharmacol Ther 28:257, 2005. PUBMED Abstract
  2. Kawabata A et al: Canine MDR-1 gene mutation in Japan, J Vet Med Sci 67(11):1103, 2005. PUBMED Abstract
  3. Mealy KL: Ivermectin: macrolide antiparasitic agents. In Peterson ME, Talcott PA, editors: Small animal toxicology, Philadelphia, 2006, Saunders, p 785.
  4. Mealy KL: Therapeutic implications of the MDR-1 gene, J Vet Pharmacol Ther 27:257, 2004.
  5. Mealy KL, Bentjen SA, Waiting DK: Frequency of mutant MDR-1 allele associated with ivermectin sensitivity in a sample population of collies from northwestern United States, Am J Vet Res 63(4):479, 2002. PUBMED Abstract
  6. Nelson OL et al: Ivermectin toxicity in an Australian Shepherd dog with the MDR-1 mutation associated with ivermectin sensitivity in collies, J Vet Intern Med 17(3):354, 2003. PUBMED Abstract
  7. Paul AJ et al: Evaluating the safety of administering high doses of chewable ivermectin tablets to collies, Vet Med 86(6):623, 1991.
  8. Pawde AM et al: Ivermectin toxicity in dogs, Indian Ass Vet Res 1(2):51, 1992.
  9. Shoop WL, Mrozik H, Fisher MH: Structure and activity of avermectins and milbemycins in animal health, Vet Parasitol 59:139, 1995. PUBMED Abstract
  10. Tranquilli WJ, Paul AJ, Todd KS: Assessment of toxicosis induced by high-dose administration of milbemycin oxime in collies, Am J Vet Res 52 (7):1170, 1991. PUBMED Abstract